NATtrol Epstein-Barr Virus Stock

(1 review) Write a Review

SKU:: NATEBV-STQ
UPC:
MPN:

Select Currency //1,021.00

Select your currency from the header

Current Stock:

Quantity:

Description
1 Review

Description

NATtrol Epstein-Barr Virus Stock - Quantitative1 mL

View AllClose

1 Review

5
its good

Posted by Lucas on 24th Nov 2021

In addition to being delivered quickly by courier, it also offered a very competitive price, thus earning five stars from me

View AllClose

Related Products

Related Products

NATtrol Cytomegalovirus CMV Strain AD-169 — Choose Options

Quick view

NATtrol Epstein-Barr Virus EBV Strain: B95-8

Select Currency //290.00 - Select Currency //1,043.00

NATtrol™ Cytomegalovirus (NATCMV-0001, NATCMV0002, NATCMV-0003, NATCMV-0004, and NATCMV-0005)* is formulated with purified, intact virus particles that have been chemically modified to render them...

NATEBV

NATtrol Epstein Barr Virus EBV Strain B95-8 Linearity Panel

Select Currency //841.00

NATtrol™ EBV Linearity Panel (NATEBV-LIN)* is formulated with purified, intact virus particles that have been chemically modified to render them non-infectious and refrigerator stable. NATEBV-LIN...

NATEBV-LIN

NATtrol Epstein Barr Virus EBV Strain B95-8 External Run Control

Select Currency //564.00 - Select Currency //632.00

NATtrol products are ready to use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel...

NATEBV-ERCL/NATEBV-ERCM

Epstein Barr Virus gp125, Human Fc

Select Currency //792.00

EPSTEIN BARR VIRUS GP125 – HUMAN FC The recombinant Epstein Barr Virus gp125 developed and manufactured by The Native Antigen Company is suitable for research and development into Epstein-Barr virus...

LGC-REC31602

Epstein Barr Virus gp125, Mouse Fc

Select Currency //792.00

EPSTEIN BARR VIRUS GP125 – MOUSE FC The recombinant Epstein Barr Virus gp125 developed and manufactured by The Native Antigen Company is suitable for research and development into Epstein-Barr virus...

LGC-REC31601